医院TAVR手术量与30天再入院率的关联
再入院病因构成不同,但住院时长和每次再入院费用无显著差异。
要点
- 高手术量医院TAVR术后30天再入院风险显著低于中、低手术量医院。
- 低手术量医院非心脏性再入院比例更高,高手术量医院心脏性再入院比例更高。
- 三组再入院的住院时长和费用无显著差异。
核心结论
- 医院TAVR手术量与30天再入院率呈负相关,高手术量医院再入院率更低且与更低的医疗系统费用相关。
研究设计与样本
- 根据年手术量将医院分为低量(<50例)、中量(≥50至<100例)和高量(≥100例)三组。
主要发现
- 30天再入院率:高量医院显著低于中量医院(调整OR 0.76,95%CI 0.68-0.85,P<.001)。
- 30天再入院率:高量医院显著低于低量医院(调整OR 0.75,95%CI 0.60-0.92,P=.007)。
- 非心脏性再入院比例低量医院为65.6%,高量医院为60.6%;心脏性再入院比例高量医院为39.4%,低量医院为34.4%。
- 住院时长(均值[SD]):低量5.5[5.0]天 vs 中量5.9[7.5]天 vs 高量6.0[5.8]天,P=.74。
- 每次再入院费用(均值[SD]):低量$13 886[18 333] vs 中量$14 135[17 939] vs 高量$13 432[15 725],P=.63。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: With the approval of transcatheter aortic valve replacement (TAVR) for patients with severe symptomatic aortic stenosis at intermediate surgical risk, TAVR volume is projected to increase exponentially in the United States. The 30-day readmission rate for TAVR was recently reported at 17.9%. The association between institutional TAVR volume and the 30-day readmission metric has not been examined. OBJECTIVE: To assess the association between hospital TAVR volume and 30-day readmission. DESIGN, SETTING, AND PARTICIPANTS: In this observational study, we used the 2014 Nationwide Readmissions Database to identify hospitals with established TAVR programs (performing at least 5 TAVRs in the first quarter of 2014). Based on annual TAVR volume, hospitals were classified as low (<50), medium (≥50 to <100), and high (≥100) volume. Rates, causes, and costs of 30-day readmissions were compared between low-, medium-, and high-volume hospitals. Data were analyzed from November to December 2016. EXPOSURE: Transcatheter aortic valve replacement. MAIN OUTCOMES AND MEASURES: Thirty-day readmissions. RESULTS: Of 129 hospitals included in this study, 20 (15.5%) were categorized as low volume, 47 (36.4%) as medium volume, and 62 (48.1%) as high volume. Of 16 252 index TAVR procedures, 663 (4.1%), 3067 (18.9%), and 12 522 (77.0%) were performed at low-, medium-, and high-volume hospitals, respectively. Thirty-day readmission rates were significantly lower in high-volume compared with medium-volume (adjusted odds ratio, 0.76; 95% CI, 0.68-0.85; P < .001) and low-volume (adjusted odds ratio, 0.75; 95% CI, 0.60-0.92; P = .007) hospitals. Noncardiac readmissions were more common in low-volume hospitals (65.6% vs 60.6% in high-volume hospitals), whereas cardiac readmissions were more common in high-volume hospitals (39.4% vs 34.4% in low-volume hospitals). There were no significant differences in length of stay and costs per readmission among the 3 groups (mean [SD], 5.5 [5.0] days vs 5.9 [7.5] days vs 6.0 [5.8] days; P = .74, and $13 886 [18 333] vs $14 135 [17 939] vs $13 432 [15 725]; P = .63, respectively). CONCLUSIONS AND RELEVANCE: We report for the first time, to our knowledge, an inverse association between hospital TAVR volume and 30-day readmissions. Lower readmission at higher-volume hospitals was associated with significantly lower cost to the health care system.
引用
- Khera S, Kolte D, Gupta T, et al. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2017. PMID: 28494061. doi:10.1001/jamacardio.2017.1630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。